Overview

Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
Female
Summary
This study evaluate role of tranexamic acid in reducing blood loss among pregnant women undergoing cesarean section because of placenta previa .Half of participants will receive tranexamia acid drug While the other half will receive placebo.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Medical Research Council
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- age 18 -38 Body mass index <30 , Diagnosis of placenta previa

Exclusion Criteria:

- patient with bleeding disorder , hepatic and renal disease. contraindication to
tranexamic acid as allergy , hypersensitivity to tranexamic acid and known
thromboembolic event during pregnancy .

other causes ofantepartum haemorrhage eg :accidental haemorrhage, rupture uterus.

type 1,2 of placenta previa anterior type 3,4 of placenta previa posterior causes of
overdistended uterus like :multiple pregnancy, polyhydraminos